Suchergebnisse - (Subject:"Siltuximab")

PubPharm (143)

1

Castleman's disease, pathophysiology, advances in diagnosis and treatment

enthalten in: Medicina clinica | 2024

von Pertusa Mataix, R. | Loaiza Cabello, D. | García Morillo, J.

2

Idiopathic multicentric Castleman disease : An update in diagnosis and treatment advances

enthalten in: Blood reviews | 2024

von Lang, E. | van Rhee, F.

3

Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab : a collection of clinical experiences

enthalten in: Drugs in context | 2024

von Rossini, B. | Cecchi, N. | Clemente, F. | +10

4

Lymphadenopathy in the rheumatology practice : a pragmatic approach

enthalten in: Rheumatology (Oxford, England) | 2023

von Rodolfi, S. | Della-Torre, E. | Bongiovanni, L. | +3

5

Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Valery, M. | Saleh, K. | Ecea, R. | +11

6

Siltuximab as a primary treatment for cytokine release syndrome in a patient receiving a bispecific antibody in a clinical trial setting

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Lipe, B. | Renaud, T.

7

Siltuximab Monotherapy in Tafro Syndrome : A Case Report and Review of the Literature

enthalten in: Journal of nephrology | 2023

von Cordero, L. | Aguilar-Rodríguez, F. | Sandino, J. | +2

8

van Rhee F, Rosenthal A, Kanhai K, et al. Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease. Blood Adv. 2022;6(16):4773-4781

enthalten in: Blood advances | 2023

9

Are Patients with HHV-8 Associated Castleman Disease Successfully Treated with Rituximab at Risk of Subsequently Developing HHV-8 Negative (Idiopathic) Castleman Disease?

enthalten in: European journal of case reports in internal medicine | 2023

von Ha, G. | Kwong, K. | Tanaka, B. | +2

10

Therapy of Castleman's disease with siltuximab - case report and review of literature

enthalten in: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti | 2023

von Adam, Z. | Zeman, D. | Chodacki, A. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]